Archives

  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-02
  • 2021-03
  • 2020-08
  • 2020-07
  • 2020-03
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • br Appendix A Supplementary data br References br T Zhang

    2022-09-15


    Appendix A. Supplementary data
    References
    [11] T. Zhang, C.F. Chan, J. Hao, G.L. Law, W.K. Wong, K.L. Wong, Fast uptake, water-soluble, mitochondria-specific erbium complex for a dual function molecular probe
    [12] Z. Hou, Y. Zhang, K. Deng, Y. Chen, X. Li, X. Deng, Z. Cheng, H. Lian, C. Li, J. Lin, UV-emitting upconversion-based TiO2 photosensitizing nanoplatform: near-infrared light mediated in vivo photodynamic therapy via mitochondria-involved apoptosis 
    R. Tian, G. Niu, G. Liu, X. Chen, Biomineralization-inspired synthesis of copper
    J. Chang, B. Zhang, Albumin-bioinspired Gd:CuS nanotheranostic agent for in vivo photoacoustic/magnetic resonance imaging-guided tumor-targeted photothermal therapy, ACS Nano 10 (2016) 10245–10257. [29] L. Li, L.H. Rashidi, M. Yao, L. Ma, L. Chen, J. Zhang, Y. Zhang, W. Chen, CuS nanoagents for photodynamic and photothermal therapies: phenomena and pos-sible mechanisms, Photodiagnosis Photodyn. Ther. 19 (2017) 5–14.
    [32] Z. Qiu, J. Shu, D. Tang, Near-infrared-to-ultraviolet light-mediated photoelec-trochemical aptasensing platform for cancer biomarker based on core-shell NaYF4:Yb, [email protected] upconversion microrods, Anal. Chem. 90 (2018) 1021–1028.
    [49] J. Li, L. Tan, X. Liu, Z. Cui, X. Yang, K.W.K. Yeung, P.K. Chu, S. Wu, Balancing bacteria-osteoblast SC 560 through selective physical puncture and bio-functionalization of ZnO/polydopamine/arginine-glycine-aspartic acid-cysteine nanorods, ACS Nano 11 (2017) 11250–11263.
    [52] G. Li, Z. Lian, W. Wang, D. Zhang, H. Li, Nanotube-confinement induced size-controllable g-C3N4 quantum dots modified single-crystalline TiO2 nanotube arrays for stable synergetic photoelectrocatalysis, Nano Energy 19 (2016) 446–454.
    Contents lists available at ScienceDirect
    International Journal of Pharmaceutics
    journal homepage: www.elsevier.com/locate/ijpharm
    Combination of microneedles and microemulsions to increase celecoxib topical delivery for potential application in chemoprevention of breast cancer 
    T
    Gabriela Mojeiko, Moacir de Brito, Giovanna C. Salata, Luciana B. Lopes
    Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Brazil
    Keywords:
    Topical delivery
    Microemulsion
    Celecoxib
    Skin
    Microneedles
    Chemoprevention 
    In spite of the high incidence of breast cancer worldwide, there are few strategies for its chemoprevention, and they have limited adherence mainly due to their serious adverse effects. As a new approach for local breast cancer chemoprevention, we developed and optimized microemulsions for topical delivery of celecoxib to the breast skin, and evaluated their combination with microneedles to improve drug penetration for localization in the mammary tissue. Microemulsions containing water at 15% (ME-15), 29% (ME-29) and 60% (ME-60) were obtained and characterized. They were isotropic, displayed Newtonian behavior and particle size smaller than 100 nm. ME-15 and ME-29 increased transepidermal water loss (TEWL) compared to ME-60, and displayed stronger vascular toxicity, evidenced by hemorrhage and lysis in HET-CAM assays. ME-60 was more efficacious at increasing celecoxib cutaneous and percutaneous delivery (1.3–4-fold). Increasing the number of microneedle roller applications from 1 to 8 increased the number of skin punctures and TEWL; its association with ME-60 promoted no further increase in TEWL, but improved (1.6–4-fold) celecoxib cutaneous and percutaneous de-livery. Microemulsion incorporation reduced celecoxib IC50 in MCF-7 cells (3.3-fold), suggesting that presence of formulation components in the mammary tissue might improve drug cytotoxicity.
    1. Introduction
    Breast cancer is the most incident malignancy for women in both high- and low-income regions, with an estimated number of cases in 2012 of 1.7 million (Ferlay et al., 2015; Kwa et al., 2017). Considering population aging, obesity, and advances in screening techniques, the incidence is destined to increase (Blucher and Stadler, 2017). New strategies for treatment have been studied along the years, including targeted drug delivery and local treatment of in situ carcinoma, but chemoprevention strategies have not received pronounced attention (Migotto et al., 2018; Naz et al., 2017; Pedrosa et al., 2015).